Overdiagnosis of bone fragility in the quest to prevent hip fracture

Abstract

Despite widespread endorsement, <b>Teppo Järvinen and colleagues</b> argue that evidence for stratifying risk of fracture and subsequent drug therapy to prevent hip fracture is insufficient to warrant our current approach